[Syndrome of depression and depigmentation after administration of combined estrogen-progestagens].
Serban
A M
AM
Teodoru
M
M
D000505:Alopecia; D001519:Behavior; D001695:Biology; D002490:Central Nervous System; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D003863:Depression; D004194:Disease; D005193:Family Planning Services; D007989:Libido; D008234:Lynestrenol; D001523:Mental Disorders; D008656:Mestranol; D010827:Physiology; D012106:Research; D012725:Sexual Behavior; D012867:Skin
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D008656:Mestranol; D008234:Lynestrenol
Alopecia; Behavior; Biology; Case Studies; Central Nervous System Effects; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Decreased Libido; Depression; Dermatological Effects; Diseases; Family Planning; Lynestrenol; Mental Disorders; Mestranol; Oral Contraceptives; Oral Contraceptives, Combined; Physiology; Research Methodology; Sex Behavior; Studies